Omicron: What governments should do, and not do
South Africa reacted with
outrage to travel bans, first triggered by the UK, imposed on it in the wake of the news that its
genomics surveillance team had detected a new variant of the SARS-CoV-2 virus.
The Network for Genomics Surveillance in South
Africa has been monitoring changes in SARS-CoV-2 since the pandemic first broke
out.
The new variant – identified as
B.1.1.529 has been declared a variant of concern by the World Health Organisation
and assigned the name Omicron.
The mutations identified in
Omicron provide theoretical concerns that the variant could be slightly more
transmissible than the Delta variant and have reduced sensitivity to antibody
activity induced by past infection or vaccines compared to how well the
antibody neutralises ancestry virus.
As vaccines differ in the
magnitude of neutralising antibody induced, the extent to which vaccines are
compromised in preventing infections due to Omicron will likely differ, as was
the case for the Beta variant.
However, as vaccines also
induce a T-cell response against a diverse set of epitopes, which appears to be
important for prevention of severe Covid, it is likely that they would still
provide comparable protection against severe Covid due to Omicron compared with
other variants.
The same was observed for the
AstraZeneca vaccine. Despite not protecting against the mild-moderate Beta
Covid in South Africa, it still showed high levels of protection (80 per cent effective)
against hospitalisation due to the Beta and Gamma variants in Canada.
In view of the new variant, there are a few steps that governments shouldn’t be taking.
And some they should be taking.
What not to do
Firstly,
don’t indiscriminately impose further restrictions, except on indoor
gatherings.
It was unsuccessful in reducing infections
over the past 3 waves in South Africa, considering 60-80 per cent people
were infected by the virus based on sero-surveys and modelling data.
At
best, the economically damaging restrictions only spread out the period of time
over which the infections took place by about 2-3 weeks.
This
is unsurprising in the South African context, where ability to adhere to the
high levels of restrictions is impractical for the majority of the population
and adherence is generally poor.
Secondly,
don’t have domestic (or international) travel bans.
The virus will disseminate irrespective of
this – as has been the case in the past.
It’s naive to believe that imposing travel
bans on a handful of countries will stop the import of a variant. This virus
will disperse across the globe unless you are an island nation that shuts off
the rest of the world.
The
absence of reporting of the variants from countries that have limited
sequencing capacity does not infer absence of the variant.
Furthermore, unless travel bans are imposed on
all other nations that still allow travel with the “red-listed” countries, the
variant will directly or indirectly still end up in countries imposing
selective travel bans, albeit perhaps delaying it slightly.
In
addition, by the time the ban has been imposed, the variant will likely have
already been spread.
This
is already evident from cases of Omicron being reported from Belgium in a
person with no links to contact with someone from Southern Africa, as well as
cases in Israel, UK and Germany.
All
travel bans accomplish in countries with selective red-listed countries is
delay the inevitable.
More
could possibly be accomplished by rigorous exit and entry screening programmes
to identify potential cases and mandating vaccination.
Third,
don’t announce regulations that are not implementable or enforceable in the
local context. And don’t pretend that people adhere to them.
This
includes banning alcohol sales, whilst being unable to effectively police the
black market.
Fourth,
don’t delay and create hurdles to boosting high risk individuals.
The
government should be targeting adults older than 65 with an additional dose of
the Pfizer vaccine after they’ve had two shots.
The
same thing goes for other risk groups such as people with kidney transplants,
or people with cancer and on chemotherapy, people with any other sort of
underlying immuno-suppressive condition.
South
Africa shouldn’t be ignoring World Health Organisation’s guidance which
recommends booster doses of high risk groups.
It
should de-prioritise, for the time being, vaccinating young children with a
single dose.
Fifth,
stop selling the herd immunity concept.
It’s
not going to materialise and paradoxically undermines vaccine confidence.
The
first generation vaccines are highly effective in protecting against severe
Covid-19, but less predictable in protecting against infection and mild
Covid due to waning of antibody and ongoing mutations of the virus.
Vaccination still reduces transmission modestly, which remains of great value,
but is unlikely to lead to “herd-immunity” in our lifetimes.
Instead
we should be talking about how to adapt and learn to live with the virus.
There
is also a list of things that should be considered in the wake of the Omicron
variant, irrespective of whether it displaces the Delta variant (which remains
unknown).
What to do
Firstly,
ensure health care facilities are prepared, not only on paper – but actually
resourced with staff, personal protective equipment and oxygen, etc.
There
are 2,000 interns and community service doctors in South Africa waiting for
their 2022 placement confirmation.
We cannot once again be found wanting with
under-prepared health facilities.
Fourth,
don’t delay and create hurdles to boosting high risk individuals.
The
government should be targeting adults older than 65 with an additional dose of
the Pfizer vaccine after they’ve had two shots. The same thing goes for other
risk groups such as people with kidney transplants, or people with cancer and
on chemotherapy, people with any other sort of underlying immuno-suppressive
condition.
South
Africa shouldn’t be ignoring World Health Organization’s guidance which
recommends booster doses of high risk groups. It should de-prioritise, for the
time being, vaccinating young children with a single dose.
Fifth,
stop selling the herd immunity concept. It’s not going to materialise and
paradoxically undermines vaccine confidence. The first generation vaccines are
highly effective in protecting against severe Covid-19, but less predictable in
protecting against infection and mild COVID due to waning of antibody and
ongoing mutations of the virus. Vaccination still reduces transmission
modestly, which remains of great value, but is unlikely to lead to
“herd-immunity” in our lifetimes.
Instead
we should be talking about how to adapt and learn to live with the virus.
There
is also a list of things that should be considered in the wake of the Omicron
variant, irrespective of whether it displaces the Delta variant (which remains
unknown).
What to do
Firstly,
ensure health care facilities are prepared, not only on paper – but actually
resourced with staff, personal protective equipment and oxygen, etc.
There
are 2000 interns and community service doctors in South Africa waiting for
their 2022 placement confirmation. We cannot once again be found wanting with
under-prepared health facilities.
Report
by Shabir A. Madhi, Dean Faculty of Health Sciences and Professor of
Vaccinology at University of the Witwatersrand; and Director of the SAMRC
Vaccines and Infectious Diseases Analytics Research Unit, University of the
Witwatersrand
Display Comments
Leave A Comment